These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8777616)

  • 1. Mortality after transurethral and open prostatectomy in Scotland.
    Hargreave TB; Heynes CF; Kendrick SW; Whyte B; Clarke JA
    Br J Urol; 1996 Apr; 77(4):547-53. PubMed ID: 8777616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and prostate cancer risk in 19,598 men after surgery for benign prostatic hyperplasia.
    Holman CD; Wisniewski ZS; Semmens JB; Rouse IL; Bass AJ
    BJU Int; 1999 Jul; 84(1):37-42. PubMed ID: 10444122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problems of comorbidity in mortality after prostatectomy.
    Concato J; Horwitz RI; Feinstein AR; Elmore JG; Schiff SF
    JAMA; 1992 Feb; 267(8):1077-82. PubMed ID: 1370963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reoperation Rates and Mortality After Transurethral and Open Prostatectomy in a Long-term Nationwide Analysis: Have We Improved Over a Decade?
    Eredics K; Wachabauer D; Röthlin F; Madersbacher S; Schauer I
    Urology; 2018 Aug; 118():152-157. PubMed ID: 29733869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in repeat prostatectomy after surgery for benign prostate disease: application of record linkage to healthcare outcomes.
    Semmens JB; Wisniewski ZS; Bass AJ; Holman CD; Rouse IL
    BJU Int; 1999 Dec; 84(9):972-5. PubMed ID: 10571622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy.
    Hahn RG; Farahmand BY; Hallin A; Hammar N; Persson PG
    Urology; 2000 Feb; 55(2):236-40. PubMed ID: 10688086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reoperation and mortality after surgical treatment of benign prostatic hypertrophy in a large prepaid medical care program.
    Sidney S; Quesenberry CP; Sadler MC; Cattolica EV; Lydick EG; Guess HA
    Med Care; 1992 Feb; 30(2):117-25. PubMed ID: 1370973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated mortality following transurethral resection of the prostate for benign hypertrophy! But why?
    Andersen TF; Brønnum-Hansen H; Sejr T; Roepstorff C
    Med Care; 1990 Oct; 28(10):870-81. PubMed ID: 1700241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SURGICAL MANAGEMENT OF BPH IN GHANA: A NEED TO IMPROVE ACCESS TO TRANSURETHRAL RESECTION OF THE PROSTATE.
    Kyei MY; Mensah JE; Morton B; Gepi-Attee S; Klufio GO; Yeboah ED
    East Afr Med J; 2012 Jul; 89(7):241-5. PubMed ID: 26845803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deaths and complications following prostatectomy in 1400 men in the northern region of England. Northern Regional Prostate Audit Group.
    Thorpe AC; Cleary R; Coles J; Vernon S; Reynolds J; Neal DE
    Br J Urol; 1994 Nov; 74(5):559-65. PubMed ID: 7530118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality after prostatectomy: selection and surgical approach.
    Seagroatt V
    Lancet; 1995 Dec; 346(8989):1521-4. PubMed ID: 7491047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early postoperative outcomes of patients undergoing prostatectomy for benign prostatic hyperplasia at Kenyatta National Hospital, Nairobi.
    Kiptoon DK; Magoha GA; Owillah FA
    East Afr Med J; 2007 Sep; 84(9 Suppl):S40-4. PubMed ID: 18154202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing comorbid-illness indices assessing outcome variation: the case of prostatectomy.
    Krousel-Wood MA; Abdoh A; Re R
    J Gen Intern Med; 1996 Jan; 11(1):32-8. PubMed ID: 8691284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia.
    Roos NP; Wennberg JE; Malenka DJ; Fisher ES; McPherson K; Andersen TF; Cohen MM; Ramsey E
    N Engl J Med; 1989 Apr; 320(17):1120-4. PubMed ID: 2469015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term incidence of acute myocardial infarction after open and transurethral resection of the prostate for benign prostatic hyperplasia.
    Shalev M; Richter S; Kessler O; Shpitz B; Fredman B; Nissenkorn I
    J Urol; 1999 Feb; 161(2):491-3. PubMed ID: 9915433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does transurethral resection of the prostate pose a risk to life? 22-year outcome.
    Koshiba K; Egawa S; Ohori M; Uchida T; Yokoyama E; Shoji K
    J Urol; 1995 May; 153(5):1506-9. PubMed ID: 7536257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of transurethral prostatectomy: a cohort study of mortality in 9,416 men.
    Cattolica EV; Sidney S; Sadler MC
    J Urol; 1997 Jul; 158(1):102-4. PubMed ID: 9186333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transurethral resection of the prostate versus open prostatectomy: long-term mortality comparison.
    Crowley AR; Horowitz M; Chan E; Macchia RJ
    J Urol; 1995 Mar; 153(3 Pt 1):695-7. PubMed ID: 7532236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia.
    Shingleton WB; Farabaugh P; May W
    Urology; 2002 Aug; 60(2):305-8. PubMed ID: 12137831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transurethral prostatectomy: a long-term follow-up study of 166 patients over 80 years of age.
    Matani Y; Mottrie AM; Stöckle M; Voges GE; Fichtner J; Hohenfellner R
    Eur Urol; 1996; 30(4):414-7. PubMed ID: 8977060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.